Figure 3.
Survival of sequenced patients. (A) Event free survival comparing Ras aberrant (red) to non-Ras aberrant (blue); (B) overall survival of Ras aberrant (red) and non-Ras aberrant (blue) patients; (C) overall survival of ALL patients with mutations predictive of Ras aberrancy (red) or non-Ras aberrant (blue). *, P<0.05. ALL, acute lymphoblastic leukemia.